Valuation VACY AS Oslo Bors

Stocks

End-of-day quote Oslo Bors Other stock markets			5-day change	1st Jan Change
- ^PTS	-.--%		-.--%	-

08-05	Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway	MT
07-22	Nykode Therapeutics AS Presents Comprehensive Preclinical Data, Optimized Manufacturing, and Durable Clinical Immunogenicity for their Individualized Neoantigen Therapy VB10.NEO	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	23,372	8,287	6,988	994.7	787.6	1,048	-	-
Change	-	-64.54%	-15.67%	-85.77%	-20.81%	33.08%	-	-
Enterprise Value (EV) ¹	21,490	6,164	5,327	-251.9	236.2	563.1	470.7	595.5
Change	-	-71.32%	-13.58%	-104.73%	193.76%	138.37%	-16.41%	26.5%
P/E	-307x	-18.1x	-16.8x	-2.28x	-6.31x	-4.97x	-34.7x	-11.6x
PBR	-	5.11x	3.85x	0.66x	0.9x	1.62x	1.45x	1.74x
PEG	-	-0x	0.9x	-0.44x	0.1x	-0.1x	0.4x	-0x
Capitalization / Revenue	74.5x	88.8x	49.5x	9.75x	182x	-	6.48x	15.1x
EV / Revenue	68.5x	66.1x	37.8x	-2.47x	54.6x	-	2.91x	8.59x
EV / EBITDA	-244x	-11.4x	-8.99x	0.49x	-0.93x	-2.1x	-5.66x	-3.79x
EV / EBIT	-228x	-11.2x	-8.66x	0.47x	-0.87x	-2.07x	-5.66x	-3.91x
EV / FCF	8,641x	-25.5x	-5.11x	0.44x	-0.84x	-4.06x	-8.49x	-4.16x
FCF Yield	0.01%	-3.92%	-19.6%	227%	-119%	-24.6%	-11.8%	-24.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.2627	-1.55	-1.271	-1.336	-0.382	-0.6465	-0.0925	-0.2775
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	313.5	93.31	141.1	102	4.326	-	161.7	69.3
EBITDA ¹	-87.93	-542.7	-592.6	-513.1	-253.5	-268	-83.16	-157.1
EBIT ¹	-94.36	-549.3	-615.1	-538.1	-273	-272.6	-83.16	-152.5
Net income ¹	-82.32	-441.7	-372.3	-432.2	-116.9	-207.9	-41.58	-97.02
Net Debt ¹	-1,882	-2,123	-1,661	-1,247	-551.4	-485.1	-577.5	-452.8
Reference price ²	80.700	28.120	21.400	3.046	2.412	3.210	3.210	3.210
Nbr of stocks (in thousands)	289,619	294,694	326,546	326,546	326,546	326,546	-	-
Announcement Date	3/31/22 A	2/28/23 A	2/28/24 A	2/26/25 A	2/25/26 A	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
WUXI APPTEC CO., LTD.	19.56x	6.76x	13.92x	1.48%	64.9B
ARGENX SE	30.78x	7.85x	23.88x	0.05%	54.05B
BIONTECH SE	-14.66x	5x	-6.67x	-.--%	23.16B
INSMED INCORPORATED	-38.21x	12.27x	-36.15x	-.--%	21.46B
WUXI BIOLOGICS (CAYMAN) INC.	26.99x	5.24x	13.87x	-.--%	21.25B
GENMAB A/S	24.71x	4.8x	15.6x	-.--%	17.94B
PHARMAESSENTIA CORPORATION	51.26x	20.9x	53.81x	0.07%	17.03B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-749.57x	35.61x	-4008.78x	-.--%	14.99B
EXELIXIS, INC.	17.89x	5.17x	12.07x	-.--%	14.25B
Average	-70.14x	11.51x	-435.38x	0.18%	27.67B
Weighted average by Cap.	-29.38x	9.65x	-229.49x	0.4%